Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.
about
Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced ParkinsonismTreatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.Review article: the treatment of functional abdominal bloating and distension.Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastomaSystematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersPathophysiology and pharmacotherapy of gastroparesis: current and future perspectives.Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.Metoclopramide in the treatment of diabetic gastroparesis.Promotility medications--now and in the future.Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia.Effect of itopride hydrochloride on the ileal and colonic motility in guinea pig in vitro.Diabetic gastroparesis: Therapeutic options.Efficacy and tolerability of levosulipride, domperidone and metoclopramide in patients with non-ulcer functional dyspepsia: a comparative analysis.Prokinetics in the Management of Functional Gastrointestinal Disorders.Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.Lessons from pharmacogenetics and metoclopramide: toward the right dose of the right drug for the right patient.Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.Convergent mechanisms in etiologically-diverse dystoniasDrugs acting on serotonin receptors for the treatment of functional GI disorders.Recent advances in the pathophysiology and treatment of gastroparesis.Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPaseEffects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.Irregular gastrointestinal drug absorption in Parkinson's disease.Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.Levosulpiride and Serum Prolactin Levels.Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)Biomagnetic methods: technologies applied to pharmaceutical research.Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents.In vitro safety pharmacology profiling: what else beyond hERG?Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement.Assaying embryotoxicity in the test tube: current limitations of the embryonic stem cell test (EST) challenging its applicability domain.Prokinetics in diabetic gastroparesis.Systemic sclerosis--challenges for clinical practice.An update on current pharmacotherapy options for dyspepsia.Evidence-based approach to dyspepsia: from Helicobacter pylori to functional disease.Current advances in treatment of gastroparesis.Safety and efficacy of commonly used antiemetics.Emerging strategies for the treatment of gastroparesis.Incidental Findings of Intense Radioiodine Uptake in Struma Ovarii and Bilateral Nonlactating Breasts Simultaneously on Postablation 131I SPECT/CT for Papillary Thyroid Cancer.Acute movement disorders in the medical setting.
P2860
Q28468282-A647E05F-F9B8-46E2-94F6-21F220A6447BQ33298440-23A83040-CDCD-43D6-A4F7-8D83B1AECC34Q33450132-82F32ED3-A77C-4EA9-9BC2-8E22341D0E7DQ33572296-ADF52ACC-27E3-4FEF-BB4A-0B87372A1C99Q34166903-57096663-59CD-4FDA-82BF-9CDE2A51B63BQ34344032-2A35E8D2-63CA-4C9F-A1C8-28D5E61A3E52Q34473834-0C441B7A-D11A-46A6-B993-B947A3E24929Q34521600-9C10308A-5267-4C65-ADDC-58E37EDAE503Q34548916-BF6D15B7-2AC0-4A18-9F03-10C1C75E22DBQ34589637-4EF6ED84-893E-4105-8BF4-969B3178427FQ34789323-04C1E943-5739-469F-BCEF-9E067C77EBECQ35054446-E223D083-FA49-49B2-81BD-60E0D9008181Q35622698-B9EF2ABC-BCB2-4F76-A8A9-C21C255E9076Q35834499-2714A110-ED1D-458A-B08D-E2550458CC2FQ35917625-A2EB159E-7AD1-40E7-A72F-5B501E8BCFB4Q36028732-B2A1C1D4-5A44-4C06-B7CC-8ABB3013DA86Q36411104-5F6026A5-A04D-40CB-9420-7EA5F177E20DQ36445234-F7291910-A341-4A6C-88AF-5BD50AACC841Q36478089-3DCF710D-B986-48CE-A251-ED5135260DD0Q36542667-45F5FB1B-DA9B-48C3-AB40-714942E291D6Q37021538-9641A8C6-AF98-425F-9EC6-D0E62310BCB7Q37056852-4A342C0E-6A10-4817-B026-1B8A9437DFEDQ37076343-72776643-6C6C-4CA5-AA01-49A82CF91BB5Q37495522-5AB0B710-E1AA-42D9-881B-5C2E8F705994Q37721964-5ACCC551-0903-4BBD-A31E-CEBF75D6D7BEQ37730595-14B138A0-7449-45BA-8B66-84792EB5648DQ37800414-731DD08E-27AF-4B2C-9355-B4A27CF6CD50Q37848438-D366D3AD-3543-46DC-AF91-55B06002F03CQ37855844-D5B26122-7F42-4803-A7FB-C3EC1FB8F49EQ37896529-69AFA7B7-F2BF-4D4F-9396-BBF21AB7CED1Q38003481-B1AEEC25-B3F3-47CA-9326-6068521390B4Q38017931-42369139-703E-4085-B6D2-085B9D5076F4Q38059459-52955D80-5EE7-46A2-8153-4509DC28C1F0Q38115358-43A499A4-16D9-44DE-B767-C336A2960D3CQ38128176-CC14D4D3-0DC3-46DD-ACD4-F4BE9A5388D7Q38550545-BE388025-936B-4CDB-914D-91B0AAE635C1Q38570496-1937D4E6-6E12-43B4-B287-95172E96E4ABQ38721476-493E5AF3-0387-44F6-BF9F-8DCE4A4A124AQ39043986-11FBFBC6-948A-4A36-BB81-138817D405DCQ39383551-D15EDF84-B6FE-4250-BF2B-CA42490C802A
P2860
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Review article: clinical impli ...... gastrointestinal prokinetics.
@ast
Review article: clinical impli ...... gastrointestinal prokinetics.
@en
type
label
Review article: clinical impli ...... gastrointestinal prokinetics.
@ast
Review article: clinical impli ...... gastrointestinal prokinetics.
@en
prefLabel
Review article: clinical impli ...... gastrointestinal prokinetics.
@ast
Review article: clinical impli ...... gastrointestinal prokinetics.
@en
P2093
P2860
P1476
Review article: clinical impli ...... gastrointestinal prokinetics.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2004.01867.X
P407
P577
2004-02-01T00:00:00Z